GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) can cause fatigue through reduced caloric intake, gastrointestinal side effects, and metabolic adjustment
This process specifically poses a potential complication when these same patients are put under anesthesia for any surgery: researchers have found that patients using GLP-1 RAs before their procedures are at a higher risk for operative aspiration
This is a significant leap from semaglutide and tirzepatide, making retatrutide a potential gold standard in obesity treatment
The GH elevation you get from 2mg daily is modest compared to running exogenous HGH at 4-6 IU
WOSINSKA: I am expecting that in retrospect, both Novo and Eli Lilly probably wish they hadn't reported the shortage
J Toxicol Clin Toxicol 19(2):173186 Aaseth J, Skaug V, Alexander J (1984) Haemolytic activity of copper as influenced by chelating agents, albumine and chromium